X-linked lymphoproliferative disease, also known as Duncan disease or Purtilo syndrome and abbreviated XLP, is a lymphoproliferative disorder usually caused by mutations in the SH2D1A gene in males. People with the disorder have immune system deficiencies that leave them unable to respond effectively to the Epstein-Barr virus, a common virus that typically causes mild symptoms or infectious mononucleosis. Two variants are currently known, XLP1 and XLP2. XLP1 is estimated to occur in about one in every million males, while XLP2 is rarer, at about one in every five million males. Because of therapies such as chemotherapy and stem cell transplants, the survival rate of XLP1 has increased dramatically since the disease was first recognized in the 1970s.
Facts
Classification
Body SystemLymphatic or Immune System 1 ICD-10 ChapterIII: Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism 2 Communicable or Non-communicable Transmission Route Causative Agent
Causative Agent (category) Prevalence Band Sources
1. X-linked lymphoproliferative disease (Wikipedia)
Lead paragraph 1
XLP-positive individuals experience immune system deficiencies
Lead paragraph 1 [causative-agent-category]
usually caused by SH2DIA gene mutations in males
View the Source2. World Health Organization: ICD-10 Version:2019 - D82.3
World Health OrganizationICD-10 2019 category D82.3, inclusion termQuote, ICD-10 2019 category D82.3, inclusion term
X-linked lymphoproliferative disease
View the Source 3. MedlinePlus Genetics (National Library of Medicine): X-linked lymphoproliferative disease - MedlinePlus Genetics
MedlinePlus Genetics (National Library of Medicine)Causes
Mutations in the SH2D1A and XIAP genes cause XLP.
Description and Inheritance
Mutations in the SH2D1A and XIAP genes cause XLP.
View the Source 4. Orphadata (Orphanet): Orphadata epidemiology, ORPHAcode 2442
Orphadata (Orphanet)Orphanet epidemiology, ORPHAcode 2442Quote, Orphanet epidemiology, ORPHAcode 2442
"PrevalenceClass": "\u003c1 / 1 000 000", "PrevalenceGeographic": "Europe", "PrevalenceQualification": "Value and class", "PrevalenceType": "Point prevalence"
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.